Taken together, these data indicate that FOXM1 a mediator of mitochondrial homeostasis and the FOXM1/MKRN1/LKB1/AMPK axis might serve as a new therapeutic target of myocardial I/R injury and HF. This evidence concerns the gene MKRN1 and hydrops fetalis.